Stock Analysis of Tarsus Pharmaceuticals Inc (TARS) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code TARS
Close 30.98
Change -2.16 / 6.52 %
Volume 1368.92 K
Vol Change 886633 / 183.84 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBearish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Low Stability Stock


Fundamental View of Tarsus Pharmaceuticals Inc
PE (TTM)

-3958.90

Very Poor
Price / Book

2408.45

Very Poor
Price / Sales

8386.53

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

1170.48 M

Enterprise Value

975747 K

ROA (TTM)

-47.74

Very Poor
ROE (TTM)

-60.84

Very Poor
Net Margin (TTM)

-211.84

Very Poor
Revenue

44.33 %

14371.00 K
Net Profit

73.28 %

-107590.00 K
Debt to Equity

0.153

Excellent
Altman Z Score

8.70

Excellent
Quick Ratio

6.85

Excellent
Cash Ratio

6.16

Excellent


Highs/Lows of Tarsus Pharmaceuticals Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week32.2 3.79 % 1.58 % 33.9829.7912-Jun-2414-Jun-24
Two Week32.96 6.01 % 2.92 % 34.7729.7903-Jun-2414-Jun-24
One Month37.99 18.45 % 3.52 % 39.6429.7915-May-2414-Jun-24
Three Month29.43 5.27 % 5.46 % 42.529.7409-May-2419-Mar-24
Six Months19.12 62.03 % 15.09 % 42.518.4509-May-2418-Dec-23
One year18.59 66.65 % 24.22 % 42.512.6609-May-2413-Oct-23
Two year12.65 144.90 % 45.41 % 42.511.3309-May-2417-Apr-23


Technical View of Tarsus Pharmaceuticals Inc
RSI

35.26

Neutral
MACD

-0.939

Bearish
ADX

16.50

Bearish
Super Trend

37.47

Bearish
Williams %R

-82.85

Mild Bullish
CCI

-116.00

Mild Bullish


EMA 5

32.22

Strong Bearish
EMA 15

33.26

Strong Bearish
EMA 50

33.99

Strong Bearish
EMA 100

31.99

Strong Bearish
SMA 100

33.45

Strong Bearish
SMA 200

25.44

Bullish
SMA 5 / 20

32.38 / 34.21

Mild Bearish
SMA 15 / 50

33.16 / 34.75

Bearish
SMA 50 / 200

34.75 / 25.44

Bullish




Charts of Tarsus Pharmaceuticals Inc


Returns of Tarsus Pharmaceuticals Inc with Peers
Period / StockTARSCTICAUTLCNTA
1 Week-3.79%0.221%12.50%15.68%
1 Mth-18.45%1.11%14.50%12.61%
3 Mth5.27%111.40%-21.05%-2.77%
6mth62.03%61.46%-9.46%45.43%
1 Year66.65%52.52%55.71%107.33%
2 Year144.90%290.13%100.00%157.07%
5 Years-78.94%-70.80%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Tarsus Pharmaceuticals Inc with Peers
Ratio / StockTARSCTICAUTLCNTA
PE-3958.90-13.95-3.78-7.15
P/B2408.45-58.233.053.87
ROA-47.74-61.83-42.65-37.19
ROE-60.840-80.74-54.17
Debt To Equity0.153-2.730.04530.320
Revenue14371.00 K
44.33 % 		53948.00 K
% 		5523.00 K
10.83 % 		6853.00 K
%
Net Income-107590.00 K
73.28 % 		-92992.00 K
5.02 % 		-158163.00 K
6.26 % 		-157421.00 K
27.19 %


Technicals of Tarsus Pharmaceuticals Inc with Peers
Technical / StockTARSCTICAUTLCNTA-
ADX16.5074.5217.2820.30
CMF-0.1650.04450.0650.089
MFI33.1933.5966.5379.03
RSI35.2683.6257.1867.48
MACD Abv SignalFalseFalseTrueTrue
Price Above 50 MAFalseTrueTrueTrue-
Price Above 200 MATrueTrueFalseTrue-


About : Tarsus Pharmaceuticals Inc

Address : 15440 Laguna Canyon Road, Irvine, CA, United States, 92618
Tel : 949 409 1801
URL : https://www.tarsusrx.com
Code : TARS, ISIN : US87650L1035, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 16_Oct_2020
Employee Count : 244

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)